Danish Pharmacovigilance Update, 18 October 2012

15 November 2012

In this issue of Danish Pharmacovigilance Update:

  • Risk of developing hepatotoxicity in patients undergoing treatment with agomelatine (Valdoxan®) (front page)
  • Cases of lactic acidosis in patients undergoing treatment with metformin for the treatment of type 2 diabetes (pp 2-3)
  • Use of MAOIs (monoamino oxidase inhibitors) and other antidepressants (p 4)
  • Restricted indications for trimetazidine (Vastarel®) (p 5)
  • Report of development of jaundice following initiation of treatment with medicines containing amoxicillin plus clavulanic acid (p 6)
  • Childhood vaccinations and adverse reactions in the second quarter of 2012 (pp 7-9)
  • Information on the safety of HPV vaccines (p 10)
  • Doctors in Denmark follow new recommendations for contraceptive pills (p 10)

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.